186
Views
31
CrossRef citations to date
0
Altmetric
Original Investigations

Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder

, , , &
Pages 190-197 | Received 21 Sep 2006, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Chiara Fabbri, Alessandro Minarini, Tomihisa Niitsu & Alessandro Serretti. (2014) Understanding the pharmacogenetics of selective serotonin reuptake inhibitors. Expert Opinion on Drug Metabolism & Toxicology 10:8, pages 1093-1118.
Read now
C. Anthony Altar, John Hornberger, Ashwini Shewade, Victor Cruz, Jill Garrison & David Mrazek. (2013) Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy. International Review of Psychiatry 25:5, pages 509-533.
Read now
Robert Keers & Katherine J Aitchison. (2011) Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics 11:1, pages 101-125.
Read now
Ulrich Rabl, Christian Scharinger, Markus Müller & Lukas Pezawas. (2010) Imaging genetics: implications for research on variable antidepressant drug response. Expert Review of Clinical Pharmacology 3:4, pages 471-489.
Read now
George I. Papakostas & Maurizio Fava. (2008) Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience 10:4, pages 439-451.
Read now

Articles from other publishers (26)

Priyanka Singh, Ankit Srivastava, Debleena Guin, Sarita Thakran, Jyoti Yadav, Puneet Chandna, Mamta Sood, Rakesh Kumar Chadda & Ritushree Kukreti. (2023) Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers. International Journal of Neuropsychopharmacology 26:10, pages 692-738.
Crossref
An-Nie Chung, Tzu-Ting Chen & Yen-Feng Lin. 2023. Treatment-Resistant Depression Part A. Treatment-Resistant Depression Part A 25 60 .
Dan Du, Qiong Tang, Qiong Han, Jin Zhang, Xuemei Liang, Youguo Tan, Kezhi Liu & Bo Xiang. (2020) Association between genetic polymorphism and antidepressants in major depression: a network meta-analysis. Pharmacogenomics 21:13, pages 963-974.
Crossref
Feifei Ren, Yufeng Ma, Xiaochen Zhu, Rongjuan Guo, Jialin Wang & Lijuan He. (2020) Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder. Journal of Affective Disorders 273, pages 254-264.
Crossref
David A. Nielsen, Huiqiong Deng, Michelle A. Patriquin, Mark J. Harding, John Oldham, Ramiro Salas, J. Christopher Fowler & B. Christopher Frueh. (2019) Association of TPH1 and serotonin transporter genotypes with treatment response for suicidal ideation: a preliminary study. European Archives of Psychiatry and Clinical Neuroscience 270:5, pages 633-642.
Crossref
Ankit Srivastava, Priyanka Singh, Hitesh Gupta, Harpreet Kaur, Neha Kanojia, Debleena Guin, Mamta Sood, Rakesh Kumar Chadda, Jyoti Yadav, Divya Vohora, Luciano Saso & Ritushree Kukreti. (2019) Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk. International Journal of Molecular Sciences 20:8, pages 1993.
Crossref
Yasmin Busch & Andreas Menke. (2018) Blood-based biomarkers predicting response to antidepressants. Journal of Neural Transmission 126:1, pages 47-63.
Crossref
G. Voegeli, M. L. Cléry-Melin, N. Ramoz & P. Gorwood. (2017) Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years. Drugs 77:18, pages 1967-1986.
Crossref
Venkata Atluri, Ravi Doddapaneni & Eliset Perez. 2017. Advances in Personalized Nanotherapeutics. Advances in Personalized Nanotherapeutics 11 23 .
Hun Soo Chang, Hwa-Young Lee, Ji-Hyun Cha, Eun Soo Won, Byung-Joo Ham, Bohye Kim & Min-Soo Lee. (2014) Interaction of 5-HTT and HTR1A Gene Polymorphisms in Treatment Responses to Mirtazapine in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology 34:4, pages 446-454.
Crossref
Olivia F. O'Leary, Fionn E. O'Brien, Richard M. O'Connor & John F. Cryan. (2014) Drugs, genes and the blues: Pharmacogenetics of the antidepressant response from mouse to man. Pharmacology Biochemistry and Behavior 123, pages 55-76.
Crossref
Barbara Breitenstein, Sandra Scheuer & Florian Holsboer. (2014) Are there meaningful biomarkers of treatment response for depression?. Drug Discovery Today 19:5, pages 539-561.
Crossref
Chiara Fabbri, Stefano Porcelli & Alessandro Serretti. (2014) From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant Treatment. The Canadian Journal of Psychiatry 59:2, pages 62-75.
Crossref
Uzoezi Ozomaro, Claes Wahlestedt & Charles B Nemeroff. (2013) Personalized medicine in psychiatry: problems and promises. BMC Medicine 11:1.
Crossref
Marina Sagud, Alma Mihaljevic-Peles, Suzana Uzun, Bjanka Vuksan Cusa, Oliver Kozumplik, Suzan Kudlek-Mikulic, Maja Mustapic, Ivan Barisic, Dorotea Muck-Seler & Nela Pivac. (2013) The lack of association between components of metabolic syndrome and treatment resistance in depression. Psychopharmacology 230:1, pages 15-21.
Crossref
Chiara Fabbri, Giulia Di Girolamo & Alessandro Serretti. (2013) Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162:6, pages 487-520.
Crossref
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini & Alessandro Serretti. (2013) Pharmacogenetics in major depression: A comprehensive meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 45, pages 183-194.
Crossref
George I. Papakostas. (2011) Surrogate markers of treatment outcome in major depressive disorder. The International Journal of Neuropsychopharmacology 15:06, pages 841-854.
Crossref
Bruno P. Guiard, Mostafa El Mansari, Dennis L. Murphy & Pierre Blier. (2011) Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. The International Journal of Neuropsychopharmacology 15:03, pages 349-361.
Crossref
Stefano Porcelli, Chiara Fabbri & Alessandro Serretti. (2012) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. European Neuropsychopharmacology 22:4, pages 239-258.
Crossref
Alessandro Serretti, Sara Gibiino & Paolo Olgiati. 2012. Neurobiology of Psychiatric Disorders. Neurobiology of Psychiatric Disorders 715 744 .
Peter P. Zandi & Jennifer T. Judy. (2010) The Promise and Reality of Pharmacogenetics in Psychiatry. Clinics in Laboratory Medicine 30:4, pages 931-974.
Crossref
Matthew J. Taylor, Srijan Sen & Zubin Bhagwagar. (2010) Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region. Biological Psychiatry 68:6, pages 536-543.
Crossref
Roy H. Perlis, Bonnie Fijal, Sweta Dharia, Alexandra N. Heinloth & John P. Houston. (2010) Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients. Biological Psychiatry 67:11, pages 1110-1113.
Crossref
Peter P. Zandi & Jennifer T. Judy. (2010) The Promise and Reality of Pharmacogenetics in Psychiatry. Psychiatric Clinics of North America 33:1, pages 181-224.
Crossref
Marco A. Grados & Rebecca Dang. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 173 182 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.